{
    "nctId": "NCT03464552",
    "officialTitle": "Role of Oral Celecoxib 200 mg in Reducing Pain Associated With Colposcopic Directed Biopsy: A Randomized Triple-blind Placebo-controlled Trial",
    "genderBased": true,
    "inclusionCriteria": "\u2022 Females 18-65 years old who undergoing colposcopic directed biopsy\n* Must be FEMALE\n* Must have minimum age of 18 Years\n* Must have maximum age of 65 Years",
    "exclusionCriteria": "* A known allergy to Celecoxib, aspirin or another NSAID.\n* Active peptic ulceration or gastrointestinal bleeding.\n* Inflammatory bowel disease.\n* Congestive heart failure (NYHA II-IV).\n* Established ischemic heart disease, peripheral arterial disease and/or cerebrovascular disease.\n* History of neurologic deficit.\n* Known hepatic or renal impairment.\n* Pregnancy.\n* Breast-feeding.\n* Post-hysterectomy.\n* Bleeding disorders.\n* Drug abuse.\n* Cervical and vaginal infection."
}